* Because there have been reports of decreased amylase activity in newborns up to 10 months, absorption rates of Arista™ AH in this population may be longer than 48 hours.
Proprietary MPH™ Technology: A Unique Approach to Achieving Hemostasis
The power of Arista™ AH lies in its proprietary MPH™ (Microporous Polysaccharide Hemospheres) technology. Consisting of microporous particles with a controlled pore size, the spheres are designed to act as a molecular sieve. The powerful osmotic action dehydrates and gels the blood on contact to accelerate the natural clotting process.
,EFFECTIVE,Absorbable Hemostatic Particles
arista powder (260 AMS), arista hemostatic agent (320 AMS), surgical hemostatic powder (N/A) /en-ca/products-and-solutions/products/product-families/arista-ah-absorbable-hemostat